• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在糖尿病和 COVID-19 大流行冲突的一年中：经验教训和未来展望。

One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.

机构信息

Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.

出版信息

J Diabetes Investig. 2022 Jan;13(1):19-21. doi: 10.1111/jdi.13644. Epub 2021 Sep 1.

DOI:10.1111/jdi.13644
PMID:34375500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8447445/
Abstract

There is a bidirectional relationship between coronavirus disease 2019 (COVID-19) and diabetes. Furthermore, the COVID-19 pandemic has catalyzed the use of technology in diabetes care. Future research is required to assess the impact of COVID-19 on new-onset diabetes and the influence of diabetes on responses to COVID-19 vaccines.

摘要

新型冠状病毒病 2019（COVID-19）与糖尿病之间存在双向关系。此外，COVID-19 大流行加速了糖尿病管理中技术的应用。需要未来的研究来评估 COVID-19 对新发糖尿病的影响，以及糖尿病对 COVID-19 疫苗反应的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a3/8756301/9ca36f181bd7/JDI-13-19-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a3/8756301/9ca36f181bd7/JDI-13-19-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a3/8756301/9ca36f181bd7/JDI-13-19-g002.jpg

相似文献

1
One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.在糖尿病和 COVID-19 大流行冲突的一年中：经验教训和未来展望。
J Diabetes Investig. 2022 Jan;13(1):19-21. doi: 10.1111/jdi.13644. Epub 2021 Sep 1.
2
COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives.沙特阿拉伯糖尿病患者中的 COVID-19：现状与新视角。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102231. doi: 10.1016/j.dsx.2021.102231. Epub 2021 Jul 24.
3
The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.三者组合：为何高血压、肥胖症和糖尿病是新冠病毒肺炎患者出现不良后果的风险因素。
Acta Diabetol. 2021 Jul;58(7):831-843. doi: 10.1007/s00592-020-01636-z. Epub 2021 Feb 15.
4
COVID-19 Pandemic and Virtual Clinics for Diabetes Care.2019冠状病毒病大流行与糖尿病护理虚拟诊所
Diabetes Technol Ther. 2021 Jun;23(S2):S3-S15. doi: 10.1089/dia.2021.2501.
5
Diabetes, obesity and COVID-19: A complex interplay.糖尿病、肥胖与 COVID-19：复杂的相互作用。
Diabetes Obes Metab. 2020 Oct;22(10):1892-1896. doi: 10.1111/dom.14134. Epub 2020 Jul 28.
6
Diabetes and COVID-19-the meeting of two pandemics: what are the concerns?糖尿病与新冠疫情——两种大流行病的交汇：有哪些担忧？
N Z Med J. 2020 May 8;133(1514):85-87.
7
An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.COVID-19 与糖尿病患者：住院环境中的病理生理学与注意事项概述。
Diabet Med. 2021 Mar;38(3):e14509. doi: 10.1111/dme.14509. Epub 2021 Feb 5.
8
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.COVID-19患者的地塞米松治疗：对糖尿病患者和非糖尿病患者血糖管理的影响及指导
Diabet Med. 2021 Jan;38(1):e14378. doi: 10.1111/dme.14378. Epub 2020 Sep 21.
9
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.COVID-19 和糖尿病：了解严重病程的相互关系和风险。
Front Endocrinol (Lausanne). 2021 Jun 17;12:649525. doi: 10.3389/fendo.2021.649525. eCollection 2021.
10
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.如何最佳保护糖尿病患者免受SARS-CoV-2的影响：国际COVID-19与糖尿病峰会报告
J Diabetes Sci Technol. 2021 Mar;15(2):478-514. doi: 10.1177/1932296820978399. Epub 2021 Jan 21.

引用本文的文献

1
A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection.急性 COVID-19 感染后伴糖调节受损的 COVID-19 幸存者血糖状态和 C-肽水平的前瞻性 1 年随访。
Diabetes Metab J. 2024 Jul;48(4):763-770. doi: 10.4093/dmj.2023.0175. Epub 2024 Mar 11.
2
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.奥密克戎变异株流行期间，未住院的 2 型糖尿病合并 SARS-CoV-2 感染患者接受莫努匹韦或奈玛特韦/利托那韦治疗后的全因住院和死亡分析。
JAMA Netw Open. 2023 May 1;6(5):e2314393. doi: 10.1001/jamanetworkopen.2023.14393.
3

本文引用的文献

1
Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan.日本在 2019 冠状病毒病疫情期间的生活方式改变及其对糖尿病患者血糖控制和体重控制的影响。
J Diabetes Investig. 2022 Feb;13(2):375-385. doi: 10.1111/jdi.13555. Epub 2021 May 7.
2
Effectiveness of remote continuous glucose monitoring on adverse outcomes among patients with diabetes complicated with COVID-19.远程连续血糖监测对合并 COVID-19 的糖尿病患者不良结局的影响。
J Diabetes Investig. 2021 Oct;12(10):1923-1924. doi: 10.1111/jdi.13537. Epub 2021 Mar 20.
3
Association of COVID-19 with hepatic metabolic dysfunction.新型冠状病毒肺炎与肝脏代谢功能障碍的关联。
World J Virol. 2022 Sep 25;11(5):237-251. doi: 10.5501/wjv.v11.i5.237.
4
The COVID-19 Vaccination Behavior and Correlates in Diabetic Patients: A Health Belief Model Theory-Based Cross-Sectional Study in China, 2021.2021年中国糖尿病患者的新冠疫苗接种行为及其相关因素：一项基于健康信念模型理论的横断面研究
Vaccines (Basel). 2022 Apr 22;10(5):659. doi: 10.3390/vaccines10050659.
Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.
在日本 2019 冠状病毒病疫情紧急状态期间，通过远程医疗或门诊就诊进行的糖尿病管理改善了血糖控制。
J Diabetes Investig. 2022 Feb;13(2):386-390. doi: 10.1111/jdi.13546. Epub 2021 Apr 8.
4
COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges.糖尿病患者的 COVID-19 疫苗接种：当前概念、不确定性与挑战
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):505-508. doi: 10.1016/j.dsx.2021.02.026. Epub 2021 Feb 25.
5
Lifestyle changes as a result of COVID-19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency.由于 COVID-19 遏制措施导致的生活方式改变：日本宣布进入紧急状态后糖尿病患者的体重和血糖控制情况。
J Diabetes Investig. 2021 Sep;12(9):1718-1722. doi: 10.1111/jdi.13526. Epub 2021 Mar 10.
6
Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.COVID-19 疫情封锁期间 1 型糖尿病患儿和青少年的血糖控制：一项基于连续血糖监测的观察性研究。
J Diabetes Investig. 2021 Sep;12(9):1708-1717. doi: 10.1111/jdi.13519. Epub 2021 Mar 2.
7
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia.患有糖尿病和 COVID-19 肺炎的患者会产生并持续产生针对 SARS-CoV-2 的强大中和抗体。
J Clin Endocrinol Metab. 2021 Apr 23;106(5):1472-1481. doi: 10.1210/clinem/dgab055.
8
Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?二甲双胍在 2 型糖尿病合并 COVID-19 患者中是“灵丹妙药”还是“洪水猛兽”？
J Diabetes Investig. 2021 Apr;12(4):479-481. doi: 10.1111/jdi.13484. Epub 2021 Jan 18.
9
Young people with type 1 diabetes on insulin pump therapy could fast safely during COVID-19 pandemic Ramadan: A telemonitoring experience in Bangladesh.孟加拉国的远程监测经验：疫情期间，使用胰岛素泵治疗的 1 型糖尿病青少年在开斋节期间可以安全禁食。
J Diabetes Investig. 2021 Jun;12(6):1060-1063. doi: 10.1111/jdi.13449. Epub 2020 Dec 10.
10
Glycemic control before admission is an important determinant of prognosis in patients with coronavirus disease 2019.入院前血糖控制是 2019 冠状病毒病患者预后的重要决定因素。
J Diabetes Investig. 2021 Jun;12(6):1064-1073. doi: 10.1111/jdi.13431. Epub 2020 Nov 8.